Internationalization is the core competence of Chinese medicine, is the company's strategic direction differentiation. Hongsen industry actively looking for other regions and countries, market demand, promote the company's internationalization with varieties of technical advantages. At the same time, through the cooperation and communication with foreign pharmaceutical companies and research institutions, learn foreign advanced management concepts, the introduction of foreign advanced technology, enhance the enterprise overall strength.
At present, the company has a number of characteristics of raw materials and intermediate products in Europe and America, Japan and South Korea and other countries are in the stage of registration. At the same time, the company more than a variety of preparations are registered in the WHO and Hongkong area.